Long-term health burden of Hodgkin lymphoma treatmentJuly 26, 2016Lymphoma & Plasma Cell DisordersPediatricsHodgkin Lymphoma
EC grants immunotherapy orphan designationJuly 22, 2016Lymphoma & Plasma Cell DisordersPharmacyTransplantationHodgkin LymphomaNon-Hodgkin Lymphoma
Drug may be curative for certain HL patientsJuly 19, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
EC extends marketing authorization for brentuximab vedotinJuly 7, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
Interim PET-CT can spare HL patients intensive chemoJune 23, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Drug can address unmet need in cHL, doc saysJune 18, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
HIV not a contraindication for transplant in lymphomaJune 17, 2016Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin Lymphoma
Delaying therapy for HL/NHL likely safe for mom, babyJune 9, 2016Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
AYAs still fare worse than kids with leukemia, lymphomaMay 31, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
CHMP recommends extending brentuximab approvalMay 28, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
PD-1 inhibitor granted accelerated approval for cHLMay 18, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
HIV patients undertreated for lymphoma, other cancersMay 18, 2016Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Childhood cancer risk linked to mother’s birthplaceApril 27, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
Drug granted breakthrough designation for cHLApril 19, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
PD-1 inhibitor granted priority review for cHLApril 15, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
